Skip to main content

Cost-effective reimbursement analysis for medical technologies in Europe

Procedure coding, payment mechanism, reimbursement tariffs, policy, and HTA considerations in 34 EU countries

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Publication Digest: The impact of different types of NHS expenditure on health: Marginal cost per QALY estimates for England for 2016/17

13 Jul 2023

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Martin et al. calculated the marginal cost per quality-adjusted life year (QALY) for different categories of care (primary care, locally commissioned secondary care, specialised services) using the data from 2016 and analysed the mortality response to healthcare expenditure on the three categories of care. The results revealed that additional investments in primary care and locally commissioned services are likely the most productive, suggesting the potential benefits of directing resources towards these categories of care.

Access the full-text article here.